Download Citation
Article Source:
Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status
Farnie G,
Willan PM,
Clarke RB,
Bundred NJ
(2013)
Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status.
PLOS ONE 8(2): e56840.
https://doi.org/10.1371/journal.pone.0056840